| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEC.2010.08.004 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S1042368010000720?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S1042368010000720?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 21109146 |
| P2093 | author name string | Nicholas Butowski | |
| P2860 | cites work | Whole brain radiotherapy for the treatment of multiple brain metastases | Q24245002 |
| Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases | Q30881868 | ||
| Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases | Q30969216 | ||
| Symptomatic management and imaging of brain metastases | Q31010312 | ||
| Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial | Q31065424 | ||
| Identification of prognostic factors in patients with brain metastases: a review of 1292 patients | Q33177750 | ||
| EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force | Q33249813 | ||
| Management of single brain metastasis: a practice guideline | Q33294727 | ||
| A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. | Q33302366 | ||
| Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site | Q33397593 | ||
| The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q33599104 | ||
| The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q33599111 | ||
| The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q33599118 | ||
| The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics | Q33599167 | ||
| Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 | ||
| Survival and prognostic factors in patients with brain metastases from malignant melanoma | Q35770850 | ||
| Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study | Q81222418 | ||
| Brain metastases | Q81465414 | ||
| Brain metastases in breast cancer: prognostic factors and management | Q81569115 | ||
| EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib. | Q35800614 | ||
| Brain metastases: epidemiology and pathophysiology. | Q36282137 | ||
| Current therapeutic approaches in patients with brain metastases | Q36619781 | ||
| Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials | Q36857456 | ||
| Melanoma-induced brain metastases | Q37159517 | ||
| Brain metastases: current management and new developments | Q37289161 | ||
| The role of chemotherapy in the treatment of patients with brain metastases from solid tumors | Q37586262 | ||
| Medical management of brain metastases from lung cancer (Review). | Q37626576 | ||
| The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline | Q37643538 | ||
| The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline | Q37643541 | ||
| The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline | Q37643544 | ||
| The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q37644237 | ||
| Multimodality management of non-small cell lung cancer patients with brain metastases | Q37654063 | ||
| Systemic treatment in breast-cancer patients with brain metastasis | Q37719556 | ||
| Brain metastases: a medical neuro-oncology perspective | Q37724219 | ||
| Modern multidisciplinary management of brain metastases | Q37738771 | ||
| Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects? | Q39406644 | ||
| Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. | Q39925540 | ||
| Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy | Q40329404 | ||
| Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines | Q41853871 | ||
| Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases | Q42633062 | ||
| Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone | Q42697397 | ||
| Evidence-linked, clinical practice guidelines-getting serious; getting professional | Q42932228 | ||
| Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy? | Q43204490 | ||
| Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases | Q44119212 | ||
| A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma | Q44303940 | ||
| Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy | Q44419098 | ||
| Prophylactic anticonvulsants in patients with brain tumour. | Q44458734 | ||
| Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial | Q44942613 | ||
| Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer | Q45098702 | ||
| Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity | Q45189921 | ||
| Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial | Q45209661 | ||
| Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. | Q46362575 | ||
| Bevacizumab safety in patients with central nervous system metastases | Q48371269 | ||
| Tumor-related prognostic factors for remission of brain metastases after radiotherapy | Q48642876 | ||
| Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group | Q73025292 | ||
| Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol | Q73615747 | ||
| Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q73816504 | ||
| A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung | Q80556492 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 27-36, v-vi | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Neurosurgery clinics of North America | Q26842825 |
| P1476 | title | Medical Management of Brain Metastases | |
| P478 | volume | 22 |
| Q38157039 | Salvage stereotactic radiosurgery for brain metastases | cites work | P2860 |
Search more.